Weekly Recap

Ocrelizumab Safety Profile in Elders, Phase 3b CASTING Trial Results, Cannabis Information Sources for MS

ByNeurologyLive® Staff

October 30th 2021

Neurology News Network for the week ending October 30, 2021.

Cenobamate Provides Long-Term Seizure Reduction, Nerivio's Impact in Chronic Migraine, Weekly Episodes Reduced With FT218

ByNeurologyLive® Staff

October 23rd 2021

Neurology News Network for the week ending October 23, 2021. [WATCH TIME: 3 minutes]

Alemtuzumab Treatment Poplation Identified, Siponimod Preserves Retinal Thickness, ATA188 Shows Success in Phase 1

ByNeurologyLive® Staff

October 16th 2021

Neurology News Network for the week ending October 15, 2021. [WATCH TIME: 3 minutes]

XEN1101 Demonstrates Efficacy in Focal Epilepsy, Long-Term Profile of Inebilizumab, Combination of Epilepsy and MS Progress Worse

ByNeurologyLive® Staff

October 9th 2021

Neurology News Network for the week ending October 9, 2021. [WATCH TIME: 3 minutes]

Study of P2B001 in PD Concludes, Verdiperstat Fails in MSA, Fenfluramine sNDA Submitted for LGS

ByMarco Meglio

October 2nd 2021

Neurology News Network for the week of October 2, 2021. [WATCH TIME: 4 minutes]

Noncontact Boxing Improves Movement in Parkinson, Riluzole's Lack of Effect in Spincerebellar Ataxia, Positive Impact of Cannabis in Dystonia

ByNeurologyLive® Staff

September 25th 2021

Neurology News Network for the week ending September 25, 2021. [WATCH TIME: 4 minutes]

AMX0035 NDA Planned, gammaCore Approved to Treat Paroxysmal Hemicrania, Epilepsy Represents Risk Factor for SUD

ByMarco Meglio

September 18th 2021

Neurology News Network for the week ending September 18, 2021.

Joint Mobilization Exercises Improve Systemic Sclerosis Spasticity, Ocrelizumab Long-Term Safety, Antiplatelets Non-Effect on Recurrent ICH

ByNeurologyLive® Staff

September 11th 2021

Neurology News Network for the week ending September 11, 2021.

Salt Substitutes Reduce Stroke Risk, Access to Rehab Disrupted by COVID-19, Headache Infusion Centers Limited

ByNeurologyLive® Staff

September 4th 2021

Neurology News Network for the week ending September 4, 2021.

Fingolimod Preserves MS Cognition, Ravulizumab ALS Trial Discontinued, ADVANCE Results Published

ByNeurologyLive® Staff

August 28th 2021

Neurology News Network for the week ending August 28, 2021.

ACTH Superior to Treat Infantile Spasms, SESI-HRMS Serves as Viable OSA Screening Tool, Myeloid Microvesicles Diagnostic Value in MS

ByNeurologyLive® Staff

August 21st 2021

Neurology News Network for the week ending August 21, 2021.

DTAS Leads to Improved Stroke Outcomes, FDA Approves Avalglucosidase Alfa, No Evidence of Suicidality in ASMs

ByNeurologyLive® Staff

August 14th 2021

Neurology News Network for the week ending August 14, 2021.

Seizure Detection Using Machine Learning, Seroconversion Rate Lower in Anti-CD20 Therapies, Age of Diabetes Onset Correlated With Dementia

ByNeurologyLive® Staff

August 7th 2021

Neurology News Network for the week ending August 7, 2021.

Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke

ByNeurologyLive® Staff

July 24th 2021

Neurology News Network for the week ending July 24, 2021.

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

ByNeurologyLive® Staff

July 17th 2021

Neurology News Network for the week ending July 17, 2021.

Narcolepsy Severity Scale Shows Benefit, Amantadine Improves Daily Living, Pridopidine's Neuroprotective Properties

ByNeurologyLive® Staff

July 10th 2021

Neurology News Network for the week ending July 10, 2021.

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

ByNeurologyLive® Staff

July 3rd 2021

Neurology News Network for the week ending July 2, 2021.

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

ByNeurologyLive® Staff

June 26th 2021

Neurology News Network for the week ending June 26, 2021.

Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs

ByNeurologyLive® Staff

June 19th 2021

Neurology News Network for the week ending June 19, 2021.

Telemedicine Produces Meaningful Migraine Improvement, Galcanezumab Shows No Wearing Effect, CGRPs All Significant Improve MMDs

ByNeurologyLive® Staff

June 12th 2021

Neurology News Network for the week ending June 12, 2021.

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

ByNeurologyLive® Staff

June 5th 2021

Neurology News Network for the week ending June 5, 2021.

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

ByNeurologyLive® Staff

May 29th 2021

Neurology News Network for the week ending May 29, 2021.

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

ByNeurologyLive® Staff

May 22nd 2021

Neurology News Network for the week ending May 22, 2021.

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

ByNeurologyLive® Staff

May 15th 2021

Neurology News Network for the week ending May 15, 2021.

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

ByNeurologyLive® Staff

May 8th 2021

Neurology News Network for the week ending May 8, 2021.

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

ByNeurologyLive® Staff

May 1st 2021

Neurology News Network for the week ending May 1, 2021.

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

ByNeurologyLive® Staff

April 24th 2021

Neurology News Network for the week ending April 24, 2021.

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

ByNeurologyLive® Staff

April 17th 2021

Neurology News Network for the week ending April 17, 2021.

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

ByNeurologyLive® Staff

April 10th 2021

Neurology News Network for the week ending April 10, 2021.

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

ByNeurologyLive® Staff

April 3rd 2021

Neurology News Network for the week ending April 3, 2021.

Weekly Recap

Ocrelizumab Safety Profile in Elders, Phase 3b CASTING Trial Results, Cannabis Information Sources for MS

Cenobamate Provides Long-Term Seizure Reduction, Nerivio's Impact in Chronic Migraine, Weekly Episodes Reduced With FT218

Alemtuzumab Treatment Poplation Identified, Siponimod Preserves Retinal Thickness, ATA188 Shows Success in Phase 1

XEN1101 Demonstrates Efficacy in Focal Epilepsy, Long-Term Profile of Inebilizumab, Combination of Epilepsy and MS Progress Worse

Study of P2B001 in PD Concludes, Verdiperstat Fails in MSA, Fenfluramine sNDA Submitted for LGS

Noncontact Boxing Improves Movement in Parkinson, Riluzole's Lack of Effect in Spincerebellar Ataxia, Positive Impact of Cannabis in Dystonia

AMX0035 NDA Planned, gammaCore Approved to Treat Paroxysmal Hemicrania, Epilepsy Represents Risk Factor for SUD

Joint Mobilization Exercises Improve Systemic Sclerosis Spasticity, Ocrelizumab Long-Term Safety, Antiplatelets Non-Effect on Recurrent ICH

Salt Substitutes Reduce Stroke Risk, Access to Rehab Disrupted by COVID-19, Headache Infusion Centers Limited

Fingolimod Preserves MS Cognition, Ravulizumab ALS Trial Discontinued, ADVANCE Results Published

ACTH Superior to Treat Infantile Spasms, SESI-HRMS Serves as Viable OSA Screening Tool, Myeloid Microvesicles Diagnostic Value in MS

DTAS Leads to Improved Stroke Outcomes, FDA Approves Avalglucosidase Alfa, No Evidence of Suicidality in ASMs

Seizure Detection Using Machine Learning, Seroconversion Rate Lower in Anti-CD20 Therapies, Age of Diabetes Onset Correlated With Dementia

Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

Narcolepsy Severity Scale Shows Benefit, Amantadine Improves Daily Living, Pridopidine's Neuroprotective Properties

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs

Telemedicine Produces Meaningful Migraine Improvement, Galcanezumab Shows No Wearing Effect, CGRPs All Significant Improve MMDs

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

NeuroVoices: Benjamin Tolchin, MD, FAAN, on First-Ever AAN Guidelines for Functional Seizures

Women Physicians Day 2026: Sex-Specific Clinical Considerations in Women With Epilepsy

Late-Breaking CHOICE 2 Data Indicate Alteplase Displayed Improved Stroke Recovery

Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis

Biomarker Data Across Studies Support Disease-Targeted Effects of Valiltramiprosate